Dermatitis News

Spherix announced it has negotiated terms to acquire a controlling interest in Hoth Therapeutics, including its BioLexa platform that is being developed to use a proprietary technology to treat eczema without traditional topical steroids.

Adults with atopic dermatitis had a significantly higher risk of developing conjunctivitis, keratitis and keratoconus compared with the general population, according to recently published study results in the Journal of the American Academy of Dermatology.

United States District Judge Kathleen M. Williams for the Southern District of Florida issued a consent decree of permanent injunction against Stratus Pharmaceuticals and Sonar Products, as well as the companies’ officers, Alberto Hoyo and Juan Carlos Billoch, for routinely shipping unapproved, misbranded and substandard or adulterated drugs in interstate commerce, according to a press release issued by the FDA.

LEO Pharma announced that the first patients have been dosed in a phase 3 study of tralokinumab for treating moderate-to-severe atopic dermatitis.

Survey findings that less than half of women assisted their husbands with skin self-examinations was among the top read articles in May on Healio.com/Dermatology.

Study results finding that long-duration phototherapy for vitiligo enhanced treatment response was among the recent developments reported on Healio.com/Dermatology.

Actress and singer Kristin Chenoweth helped kick off a campaign for Rhofade Cream 1% for treating persistent facial erythema associated with rosacea, according to a news release from Allergan.

Study results finding that most people incorrectly applied free sunscreen when it was provided at a state fair was among the top read articles of the past week on Healio.com/Dermatology.

The FDA’s acceptance of Aclaris Therapeutics’ new drug application for A-101 40% topical solution for potential treatment of seborrheic keratosis was among the top read articles of the past week on Healio.com/Dermatology.

Increasing vitamin D is unlikely to reduce the risk of pediatric and adult asthma, atopic dermatitis or other allergies, according to study results recently published in PLOS Medicine